Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells
- Rudolf Lucas(corresponding author),
- Irene Garcia,
- Yves R.A. Donati,
- Marusa Hribar,
- Stefano J. Mandriota,
- Christine Giroud
- University of Geneva,
- University Medical Center,
- Maastricht University,
- Innogenetics,
- University of Michigan, Ann Arbor,
- Aix-Marseille Université
Abstract
The conditions under which tumor necrosis factor-α (TNF) induces apoptosis in primary microvascular endothelial cells (MVEC) were investigated. In the absence of sensitizing agents, TNF induced apoptosis after 3 days of incubation in confluent MVEC. In contrast, upon addition of the transcriptional inhibitor actinomycin D (Act. D), confluence was no longer required and apoptosis occurred already after 16 h. To assess the role of either TNF receptor (TNFR) type in apoptosis, MVEC isolated from mice genetically deficient in TNFR1 (Tnfr1°mice) or TNFR2 (Tnfr2°mice) were incubated with TNF in the presence or absence of Act. D. Under sensitized conditions, Tnfr2°MVEC were lysed like controls, whereas Tnfr1°MVEC were completely resistant, indicating an exclusive role for TNFR1. In contrast, in the absence of Act. D, confluent monolayers of wild-type cells were lysed by TNF, but both Tnfr1°and Tnfr2°MVEC were resistant to TNF-mediated toxicity, indicating a requirement for both TNFR types. Overexpression of the anti-apoptotic protein bcl-xL in MVEC led to a protection against the direct, but not the sensitized cytotoxicity of TNF. In conclusion, in pathophysiologically relevant conditions, both TNFR appear to be required for TNF-induced apoptosis in MVEC.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 3577-3586 (10 pages)Journal (Volume, Issue Number)
European Journal of Immunology (Volume 28, Issue 11)Publication milestones
- Published - 11/1998
Publication status
ISSN
0014-2980Publication IDs
- Scopus: 0031795272
- PubMed: 9842900
